ストックスクリーナーアプリを入手
1.35
3.05%
0.04
前日終値:
$1.31
開ける：
$1.33
24時間の取引高:
97,953
Relative Volume:
0.08
時価総額：
$71.30M
収益：
-
当期純損益:
$-51.47M
株価収益率:
-1.35
EPS:
-1
ネットキャッシュフロー:
$-47.50M
1週間 パフォーマンス:
-2.17%
1か月 パフォーマンス:
-11.76%
6か月 パフォーマンス:
+49.77%
1年 パフォーマンス:
-16.15%
1日の値動き範囲:
$1.32
$1.3977
1週間の範囲:
$1.30
$1.46
52週間の値動き範囲:
$0.81
$1.84
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
名前
Pmv Pharmaceuticals Inc
セクター
電話
(609) 642-6670
住所
400 ALEXANDER PARK DRIVE, PRINCETON
PMVP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.34 | 69.71M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.01 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
760.62 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.15 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
921.89 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.22 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-05-13 | 開始されました | Craig Hallum | Buy |
| 2024-04-12 | 開始されました | Jefferies | Buy |
| 2023-12-27 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-02 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-09-22 | アップグレード | Goldman | Neutral → Buy |
| 2021-08-19 | 開始されました | Oppenheimer | Perform |
| 2021-08-02 | 開始されました | Guggenheim | Buy |
| 2021-07-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-20 | 開始されました | BofA Securities | Buy |
| 2020-10-20 | 開始されました | Cowen | Outperform |
| 2020-10-20 | 開始されました | Evercore ISI | Outperform |
| 2020-10-20 | 開始されました | Goldman | Neutral |
すべてを表示
Pmv Pharmaceuticals Inc (PMVP) 最新ニュース
Why PMV Pharmaceuticals Inc. stock is a must watch in 2025Trade Risk Summary & Safe Entry Zone Identification - newser.com
Why PMV Pharmaceuticals Inc. stock appeals to analysts2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
Is PMV Pharmaceuticals Inc. stock poised for growth2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
How rising interest rates impact PMV Pharmaceuticals Inc. stockPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Will PMV Pharmaceuticals Inc. stock outperform Dow Jones index2025 Price Targets & Real-Time Price Movement Reports - newser.com
Will PMV Pharmaceuticals Inc. stock benefit from commodity pricesCEO Change & Growth Oriented Trading Recommendations - newser.com
Is PMV Pharmaceuticals Inc. stock safe for conservative investorsJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Is PMV Pharmaceuticals Inc. building a consolidation base2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Top Penny Stocks To Watch In November 2025 - simplywall.st
Can PMV Pharmaceuticals Inc. stock deliver surprise earnings beat2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
HC Wainwright Issues Positive Outlook for PMVP Earnings - Defense World
Published on: 2025-11-16 01:59:30 - newser.com
Real time social sentiment graph for PMV Pharmaceuticals Inc.2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com
Sio Capital Management, LLC Reduces Stake in PMV Pharmaceuticals Inc - GuruFocus
PMV Pharmaceuticals Places Big Bet On Cancer Drug Rezatapopt - Finimize
PMV Pharmaceuticals Reports Increased Quarterly Loss - TipRanks
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential - TipRanks
PMV Pharma (PMVP) Plans NDA Submission for Ovarian Cancer Treatm - GuruFocus
PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights - The Manila Times
PMV Pharma Q3 net loss widens to $21.1 mln - MarketScreener
PMV Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] PMV Pharmaceuticals, Inc. Quarterly Earnings Report | PMVP SEC FilingForm 10-Q - Stock Titan
[8-K] PMV Pharmaceuticals, Inc. Reports Material Event | PMVP SEC FilingForm 8-K - Stock Titan
Pmv Pharmaceuticals Inc (PMVP) 財務データ
収益
当期純利益
現金流量
EPS
Pmv Pharmaceuticals Inc (PMVP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):